13F filing recap · Q1 2013
What did ArrowMark Partners buy in Q1 2013?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ArrowMark account, including accounts that belong to no fund below.
Stock value
$375.68M
Positions
100
Estimated turnover
19.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
AAPLApple Inc.$7.23Mreported value+16.3K sharesLMCALiberty Media Corporation$6.82Mreported value+61.1K sharesCPSSConsumer Portfolio Services, Inc.$2.77Mreported value+237.0K sharesAMATApplied Materials Inc /de$1.53Mreported value+113.4K sharesSTRZAStarz Entertainment Corp (liberty Capital)$1.24Mreported value+56.1K sharesNBIXNeurocrine Biosciences, Inc.$978.0Kreported value+80.4K sharesT8STesaro Inc$446.0Kreported value+20.3K sharesCLVSEURClovis Oncology Inc$329.0Kreported value+11.5K sharesHTWRHeartware International Inc$273.0Kreported value+3.1K sharesCLDXCelldex Therapeutics, Inc.$207.0Kreported value+17.9K sharesSBYSilver Bay Realty Trust Corp$196.0Kreported value+12.2K sharesAMGNAmgen Inc.$12.0Kreported value+113 shares